Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. Nat Chem Biol. 2016 10; 12(10):876-84.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.